Ponce de Leon-Ballesteros, Guillermo
Romero-Velez, Gustavo
Martinez-Portilla, Raigam Jafet
Pereira, Xavier
Roy-Garcia, Ivonne
Fobi, Mathias A. L.
Herrera, Miguel F. http://orcid.org/0000-0001-9187-9038
Article History
Received: 21 January 2022
Revised: 22 March 2022
Accepted: 31 March 2022
First Online: 22 April 2022
Declarations
:
: According to the results, BSG is a safe and effective procedure with acceptable rates of perioperative and band-related complications. Mid- (3 years) and long-term (5 years) weight loss may be superior in BSG compared to SG but may come at the expense of a higher incidence of upper GI symptoms such as food intolerance, vomiting, and regurgitation. A 6.5-cm band is associated to a higher incidence of upper GI symptoms, in comparison to a band greater than 7 cm.However, these findings are mainly based on data obtained from observational studies. Further RCT are needed to validate these results, as well as studies with longer follow-up to assess safety and efficacy of BSG at long term.This article does not contain any studies with human participants or animals performed by any of the authors.
: Non-applicable.
: Guillermo Ponce de Leon-Ballesteros has nothing to disclose. Gustavo Romero-Velez has nothing to disclose. Raigam Jafet Martinez-Portilla has nothing to disclose. Xavier Pereira has nothing to disclose. Ivonne Roy-Garcia has nothing to disclose. Mathias AL Fobi has ownership of share in Bariatec Corporation. Miguel F Herrera has nothing to disclose.